Parthenon Capital Makes Strategic Growth Investment in Medical Review Institute of America

July 8, 2024

Parthenon Capital has made a strategic growth investment in Medical Review Institute of America (MRIoA), a Salt Lake City–based provider of utilization management and clinical review solutions for payers. Summit Partners and MRIoA management will retain significant positions following the transaction; financial terms were not disclosed. Mizuho (and affiliate Greenhill & Co.) served as MRIoA's financial advisor and Kirkland & Ellis advised Parthenon.

Buyers
Parthenon Capital
Targets
Medical Review Institute of America
Sellers
Summit Partners
Location
Utah, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.